期刊名称：AMERICAN JOURNAL OF THERAPEUTICS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
American Journal of Therapeutics is an indispensable resource for all prescribing physicians who want to access pharmacological developments in cardiology, infectious disease, oncology, anesthesiology, nephrology, toxicology, and psychotropics without having to sift through stacks of medical journals. The journal features original articles on the latest therapeutic approaches as well as critical articles on the drug approval process and therapeutic reviews covering pharmacokinetics, regulatory affairs, pediatric clinical pharmacology, hypertension, metabolism, and drug delivery systems.
Instructions to Authors
SCOPE
American Journal of Therapeutics aims to place advances in pharmacotherapy into clinical perspective, grounding these advances in a pharmacoeconomic context. The journal emphasizes education in medical therapeutics and tries to accomplish this through the Clinical Therapeutic Conference reports and other original articles. The journal is dedicated to therapeutics, providing a systematic approach to covering new advances in therapeutics, as well as considering issues in clinical pharmacology, drug development, methodology of drug evaluation, and comparative aspects of pharmaceutical evaluation within a given class.
American Journal of Therapeutics features original articles on the latest therapeutic approaches, Clinical Therapeutic Conferences, clinical drug trial information, and the drug approval process. Section reviews cover pharmacokinetics, regulatory affairs, and pediatric clinical pharmacology. Issues of American Journal of Therapeutics contain these original articles plus services such as the pharmacoeconomics series, editorials, and book reviews to complete this comprehensive source of information.
Manuscript Submission
A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the journal, its editors, or the publisher.
On-line Manuscript Submission: All manuscripts must be submitted online through the new Website: http://ajt.edmgr.com.
First-time users: Please click the Register button from the menu and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor).
Authors: Please click the log-in button from the menu at the top of the page and log into the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact the editorial office.
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
General format: Submit manuscripts in English. Double space all copy including legends, footnotes, tables, and references.
Title page: Include on the title page (a) complete manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) sources of support that require acknowledgment.
The title page must also include disclosure of funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).
Unstructured abstract and key words: Limit the abstract to 250 words. It must be factual and comprehensive. Limit the use of abbreviations and acronyms, and avoid general statements (eg, 'the significance of the results is discussed'). List three to five key words or phrases.
Text: Organize the manuscript into four main headings: Introduction, Materials and Methods, Results, and Discussion. Define abbreviations at first mention in text and in each table and figure. If a brand name is cited, supply the manufacturer's name and address (city and state/country). Acknowledge all forms of support, including pharmaceutical and industry support, in an Acknowledgments paragraph.
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.
References: The authors are responsible for the accuracy of the references. Key the references (doublespaced) at the end of the manuscript. Cite the references in text in the order of appearance. Cite unpublished data, such as papers submitted but not yet accepted for publication or personal communications, in parentheses in the text. If there are more than three authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below.
Journal article
1. Willens HJ. Clopidogrel-induced mixed hepatocellular and cholestatic liver injury. Am J Ther. 2000;7:317�18.
Book chapter
2. Collins JM. Regulatory viewpoint: prediction of drug interactions from in vitro studies. In: Levy RH, Thummel KE, Trager WF, et al, eds. Metabolic Drug Interactions. Philadelphia: Lippincott Williams & Wilkins, 2000:41�0.
Entire book
3. Levy RH, Thummel KE, Trager WF, et al. Metabolic Drug Interactions. Philadelphia: Lippincott Williams & Wilkins, 2000.
Software
4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention, 1994.
Online journals
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute, 1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.
Figures: Cite figures consecutively in the text and number them in the order in which they are discussed.
Submit all artwork in digital format (see Digital figures below).
Figure legends: Legends must be submitted for all figures. They should be brief and specific, and they should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.
Color figures: The journal accepts for publication color figures that will enhance an article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.
Digital figures: Electronic art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), an EPS (encapsulated postscript) file, or a PPT (Power Point) file. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographs—radiographs, CT scans, and so on—and scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. Please note that artwork generated from office suite programs such as Corel Draw and MS Word and artwork downloaded from the Internet (JPEG or GIFF files) cannot be used.
Tables: Create tables using the table creating and editing feature of your word processing software (eg, Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Group all tables at the end of the manuscript, or supply them together in a separate file. Cite tables consecutively in the text, and number them in that order. Key each on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in USA; city and country outside USA) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius to express temperatures, and use SI units rather than conventional units.
The editorial office will acknowledge receipt of your manuscript and will give you a manuscript number for reference. Address all inquiries regarding manuscripts not yet accepted or published to the journal's editorial office.
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
Copyright: The lead author must sign a copy of the journal's "Authorship Responsibility, Financial Disclosure, and Copyright Transfer" form and submit it with the original manuscript.
Compliance with NIH and Other Research Funding Agency Accessibility Requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.
After Acceptance
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (eg, reprint order form) will be sent to the corresponding author via e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected pages to the publisher. Those authors without an e-mail address will receive traditional page proofs. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to Journal style should be allowed to stand if they do not alter the authors' meaning. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form with the electronic page proofs that includes reprint costs. Reprint requests should be faxed to the publisher with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 351 W. Camden Street, Baltimore, MD 21201; Fax: (410) 528�434; E-mail: reprints@lww.com with any questions.
Publisher's contact: Fax corrected page proofs, reprint order form, and any other related materials to 443-451-8147 (include your article reference number with the changes).
Manuscript Checklist (before submission)
Complete manuscript
Clearly labeled figures
Cover letter
Title page
Abstract
References double-spaced in journal style
Corresponding author designated, and full mailing address included, in cover letter and on title page
E-mail address of corresponding author included in cover letter and on title page
Permission to reproduce copyrighted materials or signed patient consent forms
Acknowledgments listed for grants and technical support
Completed "Manuscript Authorship Responsibility, Financial Disclosure, and Copyright Transfer" form �signed by the lead author on the behalf of all authors
Tables created using table software feature
Editorial Board
|
Editor-in-Chief |
|
John C. Somberg, MD |
|
|
Senior Editors
|
|
Andrew Whelton, MD, PhD
Richard A. Preston, MD |
|
Associate Editors
|
|
Robert L. Barkin, PharmD
Paul M. Carvey, PhD
Mihai Gheorghiade MD |
|
|
Section Editors
|
|
Therapeutic Review
Glen Apseloff, MD
Columbus, OH
Renal Drugs
Andrew Whelton, MD, PhD
Baltimore, MD
Oncology
Ronald Lieberman, MD
Rockville, MD
Peter H. Wiernik, MD
Bronx, NY
Neuropharmacology
Paul M. Carvey, PhD
Chicago, IL
Aron D. Mosnaim, PhD
North Chicago, IL
Psychopharmacology
Jan Fawcett, MD
Albuquerque, NM
Pain Management & Chemical Dependency
Robert L. Barkin, MBA, PharmD
Chicago, IL
Hypertension
Michael A. Weber, MD
New York, NY
Devices & Therapeutic Interventions
Judah Weinberger, MD, PhD
New York, NY
Anesthesia
Jonathan S. Jahr, MD
Los Angeles, CA |
Endocrinology
Gilbert Mayor, MD
Mt. Olive, NJ
Adverse Reactions
Nicholas G. Popovich, PhD, RPh
Chicago, IL
Radio Pharmaceuticals
Jeffrey S. Borer, MD
New York, NY
Regulatory
Kenneth I. Kaitin, PhD
Boston, MA
William H. Maisel, MD, MPH
Boston, MA
Rheumatology
Joel A. Block, MD
Chicago, IL
Augustine Manadan, MD
Chicago, IL
Medical Informatics
David Trace, MD
Chicago, IL
Clinical Toxicology
Jerrold Leiken, MD
Glenview, IL
Kevin S. Merigian, MD
Eads, TN
Geriatric Therapeutics
David T. Lowenthal, MD, PhD
Gainesville, FL |
|
Editorial Board |
|
Darrell Abernethy, MD, PhD
Washington, DC
Rohit Arora, MD
North Chicago, IL
Kenneth Bachmann, PhD
Toledo, OH
George L. Bakris, MD
Chicago, IL
Ross J. Baldessarini, MD
Belmont, MA
Keith Bruninga, MD
Chicago, IL
John A. Cairns, MD
Ontario, Canada
John B. Cannon, PhD
Grays Lake, IL
Clinton N. Corder, PhD, MD
Oklahoma City, OK
Timi Edeki, MD, PhD
Nashville, TN
Gerasimos S. Filippatos, MD, FACC, FCCP
Athens, Greece
William H. Frishman, MD
Westchester, NY
Ira Gelb, MD
Boca Raton, FL
Hector J. Gomez, MD, PhD
Lutz, FL
Colin W. Howden, MD
Chicago, IL
Zafer Israili, PhD
Atlanta, GA
Leonard S. Jacob, MD, PhD
Plymouth Meeting, PA
Fakhreddin Jamali, PhD
Alberta, Canada |
William J. Jusko, PhD
Buffalo, NY
William N. Kelly, PharmD
Clearwater, FL
Nicholas Kerin, MD
Detroit, MI
Mahendra S. Kochar, MD
Milwaukee, WI
Carl V. Manion, MD
Oklahoma City, OK
J.A. Jeevendra Martyn, MD
Boston, MA
Janos Molnar, MD
Chicago, IL
Peter S. Pang, MD
Chicago, IL
Amir Pelleg, PhD
Philadelphia, PA
L. Michael Prisant, MD
Augusta, GA
C. Venkata S. Ram, MD
Dallas, TX
Vasant Ranade, PhD
Chicago, IL
W.A. Ritschel, MD, PhD
Cincinnati, OH
Howard Sacher, DO
New York, NY
Solomon Sobel, MD
Rockville, MD
Manuel Velasco, MD
Los Teques, Venezuela
Matthew R. Weir, MD
Baltimore, MD
Michael S. Willett, PharmD
Paramus, NJ |
|
